Mohindru Mani
Insider CIK 1664708 · CRIS Sr. VP, Corp. Strategy & IR · CRDF Interim CEO, Director · CARA CFO & Chief Strategy Officer · CTMX Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CRDF Cardiff Oncology, Inc. | P Buy deriv | 2026-07-14 | 2026-07-16 | 34,364 | — | $0 | 34,364 | SEC↗ |
| CRDF Cardiff Oncology, Inc. | P Buy | 2026-07-14 | 2026-07-16 | 34,364 | $1.46 | $50.2K | 59,067 | SEC↗ |
| CRDF Cardiff Oncology, Inc. | P Buy | 2026-06-18 | 2026-06-22 | 24,703 | $1.21 | $29.9K | 24,703 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | A Award deriv | 2026-06-17 | 2026-06-22 | 59,000 | — | $0 | 59,000 | SEC↗ |
| CRDF Cardiff Oncology, Inc. | A Award deriv | 2026-03-31 | 2026-04-02 | 600,000 | — | $0 | 968,766 | SEC↗ |
| CRDF Cardiff Oncology, Inc. | A Award deriv | 2026-02-17 | 2026-02-18 | 200,000 | — | $0 | 368,766 | SEC↗ |
| CRDF Cardiff Oncology, Inc. | A Award deriv | 2025-06-26 | 2025-06-30 | 40,565 | — | $0 | 168,766 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | A Award deriv | 2025-06-11 | 2025-06-13 | 38,000 | — | $0 | 38,000 | SEC↗ |
| CRDF Cardiff Oncology, Inc. | A Award deriv | 2024-06-27 | 2024-07-01 | 29,700 | — | $0 | 128,201 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | A Award deriv | 2024-05-15 | 2024-05-17 | 38,000 | — | $0 | 38,000 | SEC↗ |
| CRDF Cardiff Oncology, Inc. | A Award deriv | 2023-06-15 | 2023-06-20 | 27,700 | — | $0 | 98,501 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | A Award deriv | 2023-06-14 | 2023-06-16 | 25,000 | — | $0 | 25,000 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | A Award deriv | 2022-06-15 | 2022-06-17 | 25,000 | — | $0 | 25,000 | SEC↗ |
| CRDF Cardiff Oncology, Inc. | A Award deriv | 2022-03-09 | 2022-03-10 | 26,800 | — | $0 | 70,801 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | A Award deriv | 2021-06-16 | 2021-06-17 | 20,000 | — | $0 | 20,000 | SEC↗ |
| CRDF Cardiff Oncology, Inc. | A Award deriv | 2021-06-10 | 2021-06-14 | 44,001 | — | $0 | 44,001 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | A Award deriv | 2020-12-16 | 2020-12-18 | 40,000 | — | $0 | 40,000 | SEC↗ |
| CARA Cara Therapeutics, Inc. | S Sale | 2019-12-04 | 2019-12-04 | 4,755 | $17.05 | $81.1K | 17,441 | SEC↗ |
| CARA Cara Therapeutics, Inc. | A Award | 2019-12-02 | 2019-12-04 | 8,333 | — | $0 | 22,196 | SEC↗ |
| CARA Cara Therapeutics, Inc. | M Exercise deriv | 2019-07-15 | 2019-07-17 | 37,431 | — | $0 | 299,444 | SEC↗ |
| CARA Cara Therapeutics, Inc. | M Exercise | 2019-07-15 | 2019-07-17 | 37,431 | $14.06 | $526.3K | 51,294 | SEC↗ |
| CARA Cara Therapeutics, Inc. | S Sale | 2019-07-15 | 2019-07-17 | 37,431 | $25.00 | $935.8K | 13,863 | SEC↗ |
| CARA Cara Therapeutics, Inc. | S Sale | 2019-05-29 | 2019-05-30 | 2,496 | $21.39 | $53.4K | 13,863 | SEC↗ |
| CARA Cara Therapeutics, Inc. | A Award | 2019-05-28 | 2019-05-30 | 8,333 | — | $0 | 16,359 | SEC↗ |
| CARA Cara Therapeutics, Inc. | M Exercise deriv | 2019-03-13 | 2019-03-15 | 16,041 | — | $0 | 336,875 | SEC↗ |
| CARA Cara Therapeutics, Inc. | S Sale | 2019-03-13 | 2019-03-15 | 16,041 | $19.12 | $306.7K | 8,026 | SEC↗ |
| CARA Cara Therapeutics, Inc. | M Exercise | 2019-03-13 | 2019-03-15 | 16,041 | $14.06 | $225.5K | 24,067 | SEC↗ |
| CARA Cara Therapeutics, Inc. | A Award deriv | 2019-03-06 | 2019-03-08 | 75,000 | — | $0 | 75,000 | SEC↗ |
| CARA Cara Therapeutics, Inc. | S Sale | 2018-12-28 | 2019-01-02 | 4,500 | $12.55 | $56.5K | 8,026 | SEC↗ |
| CARA Cara Therapeutics, Inc. | A Award | 2018-12-27 | 2018-12-31 | 12,526 | — | $0 | 12,526 | SEC↗ |
| CARA Cara Therapeutics, Inc. | M Exercise deriv | 2018-11-15 | 2018-11-16 | 16,042 | — | $0 | 352,916 | SEC↗ |
| CARA Cara Therapeutics, Inc. | S Sale | 2018-11-15 | 2018-11-16 | 16,042 | $18.50 | $296.8K | 0 | SEC↗ |
| CARA Cara Therapeutics, Inc. | M Exercise | 2018-11-15 | 2018-11-16 | 16,042 | $14.06 | $225.6K | 16,042 | SEC↗ |
| CARA Cara Therapeutics, Inc. | M Exercise deriv | 2018-10-17 | 2018-10-19 | 16,042 | — | $0 | 368,958 | SEC↗ |
| CARA Cara Therapeutics, Inc. | M Exercise | 2018-10-17 | 2018-10-19 | 16,042 | $14.06 | $225.6K | 16,042 | SEC↗ |
| CARA Cara Therapeutics, Inc. | S Sale | 2018-10-17 | 2018-10-19 | 16,042 | $20.19 | $323.9K | 0 | SEC↗ |
| CARA Cara Therapeutics, Inc. | A Award deriv | 2017-08-15 | 2017-08-24 | 385,000 | — | $0 | 385,000 | SEC↗ |
| CRIS CURIS INC | A Award deriv | 2017-02-14 | 2017-02-16 | 424,000 | — | $0 | 424,000 | SEC↗ |
| CRIS CURIS INC | A Award deriv | 2016-03-29 | 2016-03-30 | 200,000 | — | $0 | 200,000 | SEC↗ |
| CRIS CURIS INC | A Award deriv | 2016-01-19 | 2016-01-25 | 100,000 | — | $0 | 100,000 | SEC↗ |